WuXi AppTec’s stock tumbles 8.47% after announcing a major share sale
WuXi AppTec's Shanghai shares experienced a significant drop of 8.47% following the announcement of a planned share sale. The company, which has been focusing on global expansion, recently divested non-core businesses and announced a major project in Saudi Arabia.
WuXi AppTec Co. Ltd. has been streamlining its operations in China, selling two non-core businesses that generated a combined 1.16 billion yuan in revenue and 0.09 billion yuan in net profit in the first three quarters of 2025. The company sold WuXi Clinical and WuXi MedKey to Hillhouse Investment Management for 2.8 billion yuan ($390 million).
In a strategic move, WuXi AppTec has signed a memorandum of understanding with its Saudi partners to build a global entry research and manufacturing base in NEOM. This project, a collaboration with NEOM and the Saudi Ministry of Health, aims to strengthen WuXi AppTec's global supply chain.
The company's financial performance has been robust. In the first nine months of 2025, WuXi AppTec's revenue rose by 18.61% and net profit soared by 84.84% compared to the same period in 2024. Key shareholders plan to sell up to 2% of the company's A-share capital due to personal funding needs.
WuXi AppTec's share price plummeted after the planned share sale was announced. However, the company's focus on global expansion, including the NEOM global entry project, and its strong financial performance could renew investor interest if it successfully bolsters its resilience and global presence.
Read also:
- India's Agriculture Minister Reviews Sector Progress Amid Heavy Rains, Crop Areas Up
- Cyprus, Kuwait Strengthen Strategic Partnership with Upcoming Ministerial Meeting
- Inspired & Paddy Power Extend Virtual Sports Partnership for UK & Ireland Retail
- South West & South East England: Check & Object to Lorry Operator Licensing Now
